Axa Other Operating Expenses vs Ebit Analysis

EQH Stock

USD 54.08 0.70 1.31%

Axa Equitable financial indicator trend analysis is way more than just evaluating Axa Equitable Holdings prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Axa Equitable Holdings is a good investment. Please check the relationship between Axa Equitable Other Operating Expenses and its Ebit accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Axa Equitable Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index.

Other Operating Expenses vs Ebit

Other Operating Expenses vs Ebit Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Axa Equitable Holdings Other Operating Expenses account and Ebit. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Axa Equitable's Other Operating Expenses and Ebit is -0.37. Overlapping area represents the amount of variation of Other Operating Expenses that can explain the historical movement of Ebit in the same time period over historical financial statements of Axa Equitable Holdings, assuming nothing else is changed. The correlation between historical values of Axa Equitable's Other Operating Expenses and Ebit is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Operating Expenses of Axa Equitable Holdings are associated (or correlated) with its Ebit. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ebit has no effect on the direction of Other Operating Expenses i.e., Axa Equitable's Other Operating Expenses and Ebit go up and down completely randomly.

Correlation Coefficient

-0.37

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Axa Equitable Holdings. It is also known as Axa Equitable overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Ebit

Most indicators from Axa Equitable's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Axa Equitable Holdings current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Axa Equitable Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index.

As of now, Axa Equitable's Tax Provision is increasing as compared to previous years. The Axa Equitable's current Enterprise Value Over EBITDA is estimated to increase to 7.59, while Selling General Administrative is projected to decrease to under 2.4 B.

	2022	2023	2024	2025 (projected)
Gross Profit	10.4B	6.3B	10.0B	7.5B
Total Revenue	12.6B	10.5B	12.4B	9.3B

Gross Profit Total Revenue

Axa Equitable fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Good Will	Short Term Investments	Long Term Debt Total	Non Current Liabilities Total	Capital Surpluse	Other Current Assets	Other Stockholder Equity	Total Liab
Common Stock Shares Outstanding		0.31	0.59	-0.67	0.07	0.74	-0.88	0.73	-0.17	0.38	-0.83	0.48	-0.2	-0.76	0.52	0.2	0.59	-0.59	-0.59	-0.33	0.62	-0.4	-0.89	-0.74	0.98	0.27
Total Assets	0.31		0.25	-0.04	-0.11	0.56	-0.14	0.51	-0.73	0.2	-0.51	0.72	0.66	-0.7	0.65	0.04	0.31	0.19	-0.76	-0.18	0.19	0.24	-0.14	0.02	0.38	1.0
Short Long Term Debt Total	0.59	0.25		-0.46	0.14	0.49	-0.49	0.48	0.1	0.52	-0.53	0.13	-0.01	-0.43	0.43	0.77	0.13	-0.39	-0.54	-0.25	0.92	-0.14	-0.4	-0.46	0.61	0.23
Other Current Liab	-0.67	-0.04	-0.46		-0.26	-0.33	0.78	-0.37	0.11	-0.44	0.53	-0.31	0.15	0.34	0.05	-0.17	-0.59	0.9	0.15	0.39	-0.45	0.19	0.57	0.65	-0.7	-0.02
Total Current Liabilities	0.07	-0.11	0.14	-0.26		-0.23	-0.25	-0.25	-0.07	-0.08	0.12	0.35	0.22	0.26	-0.41	0.28	0.28	-0.13	0.38	-0.59	0.06	0.41	-0.25	-0.52	0.12	-0.1
Total Stockholder Equity	0.74	0.56	0.49	-0.33	-0.23		-0.38	0.99	-0.38	0.5	-0.51	0.39	-0.01	-0.85	0.76	0.27	0.59	-0.39	-0.85	0.1	0.61	-0.37	-0.49	-0.32	0.75	0.52
Other Liab	-0.88	-0.14	-0.49	0.78	-0.25	-0.38		-0.37	0.14	-0.25	0.83	-0.52	0.12	0.48	-0.18	-0.05	-0.45	0.63	0.28	0.62	-0.42	0.18	0.87	0.81	-0.86	-0.11
Net Tangible Assets	0.73	0.51	0.48	-0.37	-0.25	0.99	-0.37		-0.33	0.52	-0.49	0.33	-0.07	-0.84	0.72	0.27	0.61	-0.44	-0.83	0.14	0.62	-0.42	-0.47	-0.3	0.75	0.46
Net Debt	-0.17	-0.73	0.1	0.11	-0.07	-0.38	0.14	-0.33		-0.05	0.27	-0.83	-0.77	0.33	-0.21	0.31	-0.44	-0.02	0.41	0.4	0.17	-0.54	0.14	0.11	-0.2	-0.73
Retained Earnings	0.38	0.2	0.52	-0.44	-0.08	0.5	-0.25	0.52	-0.05		-0.22	-0.03	0.06	-0.31	0.17	0.65	0.03	-0.52	-0.38	-0.09	0.65	-0.07	0.04	0.07	0.49	0.17
Accounts Payable	-0.83	-0.51	-0.53	0.53	0.12	-0.51	0.83	-0.49	0.27	-0.22		-0.56	-0.08	0.69	-0.51	-0.02	-0.33	0.29	0.66	0.47	-0.47	0.16	0.74	0.52	-0.81	-0.49
Cash	0.48	0.72	0.13	-0.31	0.35	0.39	-0.52	0.33	-0.83	-0.03	-0.56		0.64	-0.48	0.27	-0.19	0.55	-0.07	-0.43	-0.64	0.01	0.43	-0.51	-0.48	0.51	0.72
Non Current Assets Total	-0.2	0.66	-0.01	0.15	0.22	-0.01	0.12	-0.07	-0.77	0.06	-0.08	0.64		0.04	-0.04	0.01	-0.03	0.36	-0.25	-0.52	-0.13	0.88	0.24	0.19	-0.12	0.69
Non Currrent Assets Other	-0.76	-0.7	-0.43	0.34	0.26	-0.85	0.48	-0.84	0.33	-0.31	0.69	-0.48	0.04		-0.88	-0.08	-0.54	0.25	0.81	-0.1	-0.45	0.47	0.56	0.32	-0.78	-0.67
Other Assets	0.52	0.65	0.43	0.05	-0.41	0.76	-0.18	0.72	-0.21	0.17	-0.51	0.27	-0.04	-0.88		0.14	0.21	0.07	-0.78	0.29	0.4	-0.45	-0.35	-0.12	0.51	0.62
Long Term Debt	0.2	0.04	0.77	-0.17	0.28	0.27	-0.05	0.27	0.31	0.65	-0.02	-0.19	0.01	-0.08	0.14		-0.11	-0.2	-0.26	-0.08	0.83	-0.02	0.06	-0.06	0.28	0.02
Cash And Short Term Investments	0.59	0.31	0.13	-0.59	0.28	0.59	-0.45	0.61	-0.44	0.03	-0.33	0.55	-0.03	-0.54	0.21	-0.11		-0.52	-0.36	-0.1	0.22	-0.22	-0.63	-0.61	0.59	0.28
Net Receivables	-0.59	0.19	-0.39	0.9	-0.13	-0.39	0.63	-0.44	-0.02	-0.52	0.29	-0.07	0.36	0.25	0.07	-0.2	-0.52		0.06	0.16	-0.44	0.34	0.45	0.58	-0.61	0.22
Good Will	-0.59	-0.76	-0.54	0.15	0.38	-0.85	0.28	-0.83	0.41	-0.38	0.66	-0.43	-0.25	0.81	-0.78	-0.26	-0.36	0.06		-0.01	-0.61	0.17	0.35	0.1	-0.6	-0.73
Short Term Investments	-0.33	-0.18	-0.25	0.39	-0.59	0.1	0.62	0.14	0.4	-0.09	0.47	-0.64	-0.52	-0.1	0.29	-0.08	-0.1	0.16	-0.01		-0.12	-0.64	0.42	0.5	-0.35	-0.18
Long Term Debt Total	0.62	0.19	0.92	-0.45	0.06	0.61	-0.42	0.62	0.17	0.65	-0.47	0.01	-0.13	-0.45	0.4	0.83	0.22	-0.44	-0.61	-0.12		-0.27	-0.37	-0.34	0.66	0.16
Non Current Liabilities Total	-0.4	0.24	-0.14	0.19	0.41	-0.37	0.18	-0.42	-0.54	-0.07	0.16	0.43	0.88	0.47	-0.45	-0.02	-0.22	0.34	0.17	-0.64	-0.27		0.33	0.16	-0.35	0.27
Capital Surpluse	-0.89	-0.14	-0.4	0.57	-0.25	-0.49	0.87	-0.47	0.14	0.04	0.74	-0.51	0.24	0.56	-0.35	0.06	-0.63	0.45	0.35	0.42	-0.37	0.33		0.9	-0.82	-0.11
Other Current Assets	-0.74	0.02	-0.46	0.65	-0.52	-0.32	0.81	-0.3	0.11	0.07	0.52	-0.48	0.19	0.32	-0.12	-0.06	-0.61	0.58	0.1	0.5	-0.34	0.16	0.9		-0.68	0.05
Other Stockholder Equity	0.98	0.38	0.61	-0.7	0.12	0.75	-0.86	0.75	-0.2	0.49	-0.81	0.51	-0.12	-0.78	0.51	0.28	0.59	-0.61	-0.6	-0.35	0.66	-0.35	-0.82	-0.68		0.34
Total Liab	0.27	1.0	0.23	-0.02	-0.1	0.52	-0.11	0.46	-0.73	0.17	-0.49	0.72	0.69	-0.67	0.62	0.02	0.28	0.22	-0.73	-0.18	0.16	0.27	-0.11	0.05	0.34

Click cells to compare fundamentals

Axa Equitable Account Relationship Matchups

Axa Equitable fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Common Stock Shares Outstanding	450.4M	417.4M	379.9M	351.6M	318.2M	379.0M
Total Assets	282.3B	292.3B	252.7B	276.8B	8.9B	8.4B
Short Long Term Debt Total	4.1B	5.1B	5.2B	5.6B	3.8B	5.4B
Other Current Liab	(2.8B)	13.9B	(714M)	2.2B	2.5B	2.7B
Total Current Liabilities	2.8B	2.8B	3.0B	5.1B	4.6B	2.8B
Total Stockholder Equity	15.6B	11.5B	1.4B	2.6B	1.6B	1.5B
Other Liab	215.6B	251.1B	272.3B	232.4B	267.3B	237.9B
Net Tangible Assets	7.7B	11.0B	5.2B	(3.4B)	(3.0B)	(2.9B)
Net Debt	(2.1B)	(66M)	950M	(2.6B)	2.2B	2.3B
Retained Earnings	10.7B	8.9B	9.8B	10.2B	10.6B	8.8B
Accounts Payable	2.8B	2.7B	2.2B	2.7B	4.1B	2.7B
Cash	6.2B	5.2B	4.3B	8.2B	1.6B	1.5B
Non Current Assets Total	93.8B	88.2B	74.2B	243.3B	2.0B	1.9B
Non Currrent Assets Other	(93.8B)	(88.2B)	(1.2B)	229.7B	264.2B	277.4B
Other Assets	93.5B	181.6B	81.1B	5.3B	5.3B	5.0B
Long Term Debt	4.1B	5.0B	4.5B	5.4B	5.9B	4.6B
Cash And Short Term Investments	88.2B	5.2B	4.3B	9.4B	1.6B	1.5B
Net Receivables	6.8B	17.3B	11.6B	12.2B	8.0B	10.1B
Good Will	4.6B	4.6B	5.1B	5.1B	5.9B	5.3B
Short Term Investments	82.0B	79.9B	64.9B	1.5B	76.6B	60.1B
Long Term Debt Total	6.4B	4.1B	3.9B	3.3B	3.0B	4.4B
Liabilities And Stockholders Equity	282.3B	292.3B	252.7B	276.8B	8.9B	8.4B
Non Current Liabilities Total	4.9B	5.0B	3.3B	256.5B	3.8B	3.6B
Capital Surpluse	1.9B	2.0B	1.9B	2.3B	2.6B	1.8B
Other Current Assets	21.3B	27.6B	29.7B	18.8B	21.6B	18.2B
Other Stockholder Equity	(260M)	(931M)	(998M)	(1.4B)	(1.9B)	(1.8B)
Total Liab	265.0B	278.7B	249.1B	271.7B	7.3B	6.9B
Deferred Long Term Liab	5.9B	749M	5.5B	8.2B	7.4B	4.5B
Long Term Investments	109.1B	105.1B	93.1B	75.2B	85.0B	85.6B
Total Current Assets	95.0B	22.5B	97.4B	28.2B	1.6B	1.5B
Accumulated Other Comprehensive Income	3.9B	2.0B	(9.0B)	(7.8B)	(8.7B)	(8.3B)
Short Term Debt	4.1B	92M	759M	254M	228.6M	217.2M
Intangible Assets	4.7B	4.7B	5.5B	5.4B	6.2B	4.5B
Cash And Equivalents	4.4B	6.2B	5.2B	4.3B	3.9B	4.0B
Net Invested Capital	18.7B	15.1B	5.3B	6.7B	6.0B	10.7B
Warrants	365M	143M	468M	455M	523.3M	356.0M
Noncontrolling Interest In Consolidated Entity	1.6B	1.6B	1.6B	1.7B	2.0B	1.8B
Retained Earnings Total Equity	11.8B	10.7B	8.9B	9.9B	8.9B	8.9B

Currently Active Assets on Macroaxis

CRM	Salesforce
C	Citigroup
GM	General Motors
WD	Walker Dunlop
MSFT	Microsoft

When determining whether Axa Equitable Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Axa Equitable's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Axa Equitable Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Axa Equitable Holdings Stock:

How To Invest In Axa

Details

Is Axa Stock a good investment?

Details

What is Axa Equitable's Net Worth?

Details

Largest Diversified Financial Services Companies

View

Largest Financial Services Companies

View

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Axa Equitable Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index.

You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Is Diversified Financial Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Axa Equitable. If investors know Axa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Axa Equitable listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.40)

Dividend Share

0.96

Earnings Share

3.78

Revenue Per Share

38.72

Quarterly Revenue Growth

0.946

The market value of Axa Equitable Holdings is measured differently than its book value, which is the value of Axa that is recorded on the company's balance sheet. Investors also form their own opinion of Axa Equitable's value that differs from its market value or its book value, called intrinsic value, which is Axa Equitable's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Axa Equitable's market value can be influenced by many factors that don't directly affect Axa Equitable's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Axa Equitable's value and its price as these two are different measures arrived at by different means. Investors typically determine if Axa Equitable is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Axa Equitable's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Axa Other Operating Expenses vs Ebit Analysis

Other Operating Expenses vs Ebit

Other Operating Expenses vs Ebit Correlation Analysis

Correlation Coefficient

Other Operating Expenses

Ebit

Axa Equitable fundamental ratios Correlations

Axa Equitable Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Axa Equitable fundamental ratios Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Liab	+ 1.0	Total Assets
Net Tangible Assets	+ 0.99	Total Stockholder Equity
Other Stockholder Equity	+ 0.98	Common Stock Shares Outstanding
Long Term Debt Total	+ 0.92	Short Long Term Debt Total
Net Receivables	+ 0.9	Other Current Liab
Other Current Assets	+ 0.9	Capital Surpluse

Capital Surpluse	- 0.89	Common Stock Shares Outstanding
Other Assets	- 0.88	Non Currrent Assets Other
Other Liab	- 0.88	Common Stock Shares Outstanding
Other Stockholder Equity	- 0.86	Other Liab
Good Will	- 0.85	Total Stockholder Equity
Non Currrent Assets Other	- 0.85	Total Stockholder Equity